JESSICA LOCKWOOD: Open Payments
NPI 1073792891 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,296 in 65 payments from 18 companies in 2025. Trend: 2023 $487 · 2024 $639 · 2025 $1,296
Food & beverage: $1,286Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $242 |
| Janssen Biotech, Inc. | 7 | $157 |
| Lilly USA, LLC | 7 | $126 |
| Ardelyx, Inc. | 3 | $91 |
| Madrigal Pharmaceuticals | 2 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $68 |
| Celltrion USA Inc. | 2 | $46 |
| Gilead Sciences, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: ENTYVIO, TREMFYA, RINVOQ, OMVOH, IBSRELA, REZDIFFRA, EOHILIA, IQIRVO.
Industry payments across NY — which companies pay providers there.
